Profile
Ghanshyam Patil is the founder of Othera Pharmaceuticals, Inc., which was founded in 2002.
He holds the title of SVP-Research & Development at Othera Pharmaceuticals, Inc. Dr. Patil also held former positions at Bristol Myers Squibb Co., DuPont Merck Pharmaceutical Co., Acucela, Inc., and Dupont Critical Care, Inc. His former titles include Principal at Bristol Myers Squibb Co., DuPont Merck Pharmaceutical Co., and Dupont Critical Care, Inc., and Vice President-Research & Development at Acucela, Inc.
Ghanshyam Patil active positions
| Companies | Position | Start |
|---|---|---|
Othera Pharmaceuticals, Inc.
 Othera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2002, Othera Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing treatments for ophthalmic diseases. Othera is also engaged in the discovery of a novel set of orally available compounds to address severe medical conditions including inflammatory and oncology-related diseases. | Founder | 01/09/2009 |
Former positions of Ghanshyam Patil
| Companies | Position | End |
|---|---|---|
| ACUCELA INC | Chief Tech/Sci/R&D Officer | - |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Dupont Critical Care, Inc. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 4 |
|---|---|
Othera Pharmaceuticals, Inc.
Othera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2002, Othera Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing treatments for ophthalmic diseases. Othera is also engaged in the discovery of a novel set of orally available compounds to address severe medical conditions including inflammatory and oncology-related diseases. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| Dupont Critical Care, Inc. |
- Stock Market
- Insiders
- Ghanshyam Patil
